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Aim: To assess the effects of each traditional cardiovascular risk factor (hypertension, diabetesmellitus, dyslipid-
emia, and smoking), including the presence of coronary artery disease (CAD), on carotid intima-media thickness
(CIMT) and to assess the degree of carotid plaque occurrence.
Methods:A total of 553 outpatients (216men and 337women;mean age 67.06± 12.44 years) who underwent a
carotid artery ultrasound were screened for carotid plaque and CIMT measurements.
Results: The CIMTmedians were higher in males (P b .001) and in patients with hypertension (P b .001). A linear
increase occurred inmean CIMT of 0.0059mm for each year of increase in age. The presence of plaque indicated a
tendency to correlate with CIMT (P= .067). The presence of hypertension associated with diabetes (P= .0061;
estimated difference 0.0494mm) or dyslipidemia (P= .0016; estimated difference 0.0472mm) or CAD (P= .0043;
estimated difference 0.0527mm) increased themean CIMTmeasurements. The probability of plaque occurrence in
carotid arteries is inﬂuenced by the age (P b .001) and is higher in patients with dyslipidemia (P= .008) and CAD
(P b .001).
Conclusions: Hypertension is the strongest cardiovascular risk factor that increases CIMT, followed by age and male
sex. Age and dyslipidemia increase the probability of carotid plaque. Increased CIMT and plaque could be present in
the same patient caused by different risk factors and with independent effects on the artery wall and different clin-
ical prognoses.
© 2015 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CCBY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Since 1986when Pignoli et al. [1], in an in vitro study, concluded that
Bmode imaging represents a useful tool for detection andmonitoring of
changes in intimal + medial thickness and allows the evaluation of
changes in the arterial wall in areas without localized plaques, carotid
intima-media thickness (CIMT)measurements have been used in sever-
al observational and interventions studies [2–3]. The noninvasive na-
ture of this approach became a recommendation for its use in the pre-
clinical diagnosis and follow-up of patients with atherosclerosis. CIMT
is widely used in clinical research for testing the value of new and
emerging risk factors and for evaluation of the effects of various drugs
on risk factor modiﬁcations [2]. CIMT is considered a reﬂection of multi-
ple risk factors; however, primary contributors to intima-media thick-
ening are age and hypertension, which do not necessarily reﬂect the
atherosclerotic process [3–5]. The primary limitation of CIMT is its in-
ability to distinguish lesions with a necrotic core considered a key.V. Baroncini).
reability and freedom from bias
land Ltd. This is an open access articleindicator of signiﬁcant plaque advancement and a recognized feature
of lesion vulnerability [3]. CIMT and carotid plaque, although correlated,
reﬂect different stages and aspects of atherosclerosis and have distinct
determinants [6]. A hypertensive hypertrophic response of medial
cells can be observed in early phases of atherosclerosis, while carotid
plaque formation is often seen in later stages of atherosclerosis and
may be caused by inﬂammation, oxidation, and endothelial dysfunction
or smooth muscle cell proliferation, or both [7]. The objective of the
present study was to assess the different effects of each traditional car-
diovascular risk factor (hypertension, diabetes mellitus, dyslipidemia,
and smoking), including also the presence of coronary artery disease
(CAD) on CIMT and the presence of carotid plaque. The correlation be-
tween the presence of plaque and CIMT was also investigated.
2. Methods
2.1. Patients
The subjectswere selected from a private cardiology clinic next to the
ultrasound laboratory. All patientswere under the care of a private cardi-
ologist, who assessed the results of blood samples, collected from sub-
jects after overnight fasting. The cardiologist used standard techniquesunder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Table 1
Patient's baseline characteristics.
Patients with risk factors (N/%) 450 (81.3%)
Sex (M/F) 174/276
Age (y ± SD) 67.6 ± 11.7
Carotid plaque (N/%) 107 (23.8)
History of hypertension (N/%) 333 (74)
History of dyslipidemia (N/%) 249 (55.3)
History of diabetes mellitus (N/%) 100 (22.2)
Cardiovascular history (N/%) 71 (15.7)
Current smoking (N/%) 65 (14.4)
Patients without risk factors (N/%) 103 (18.62)
Sex (M/F) 41/62
Age (y ± SD) 64.6 ± 15.1
Carotid plaque (N/%) 12 (11.6)
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(HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, and triglyc-
erides. The decision to perform a carotid artery study was made exclu-
sively by the private cardiologist. A total of 553 consecutive outpatients
(216 men and 337 women; mean age 67.06 ± 12.44 years) who
underwent a carotid artery ultrasound were screened for carotid plaque
and CIMTmeasurement, during a period of 6 months. There were no ex-
clusion criteria. Before the study, the ultrasonographist collected infor-
mation on demographic characteristics and risk factors for each patient
according to the report from the private cardiologist. Patients were
asked about the presence of hypertension, diabetes mellitus, dyslipid-
emia, coronary artery disease, and current smoking habit. Hypertension
was deﬁned as a history of treatedhypertension or the presence of systol-
ic BP ≥ 140mmHgor diastolic BP ≥ 90mmHg asmeasured by the private
cardiologist. Smoking historywas coded as never or current smoker. Sub-
jects were classiﬁed as having diabetes when treated for insulin-
dependent or non-insulin-dependent diabetes or having elevated fasting
glucose levels (≥126mg/dL). The use of lipid-lowering drugs or the pres-
ence of total cholesterol N200 mg/dL, HDL-cholesterol b40 mg/dL, LDL-
cholesterol N100 mg/dL or triglycerides N150 mg/dL was recorded. No
patient at the present study had a history of stroke or transient ischemic
attack and no patient complained of intermittent claudication suggesting
peripheral arterial disease. A history of myocardial infarction, angioplas-
ty, or coronary artery by-pass surgery was recorded and a positive CAD
history was deﬁned as the presence of any of these diseases in conjunc-
tion with the evaluation report from the private cardiologist. Local Insti-
tutional ethical committee approvalwas obtained for the study. Informed
consentwas obtained from each patient and the study protocol conforms
to the ethical guidelines of the 1975Declaration ofHelsinki as reﬂected in
a priori approval by the institution's human research committee.
2.2. Ultrasound measurements
Measurements were made with a high-resolution B-mode ultraso-
nography (Philips Medical Systems' HD11 platform) with a broadband
width linear array transducer L 3–12 MHz. Sonography and readings
were carried out by trained certiﬁed sonographers. On longitudinal 2D
ultrasound images of the carotid artery, the near wall and the far wall
are displayed as 2 echogenic lines (the adventitia and intima) that are
separated by the hypoechoic media. The distance between the leading
edge of the ﬁrst bright line of the far wall (lumen-intima interface)
and the leading edge of the second bright line (media-adventitia inter-
face) is deﬁned as the CIMT. Measurements of CIMT were taken manu-
ally on the distal 10 mm of both right and left common carotid arteries
in the farwall. Five determinationswere conducted on each side and the
average measurement was used for the CIMT, according to Brazilian
Cardiovascular Imaging Department Task Force for Carotid Ultrasound
[8]. An artery was classiﬁed as being affected by plaque if there was a
focal wall thickening at least 50% greater than that of the surrounding
vessel wall or a localized region with CIMT greater than 1.5 mm that
did not uniformly involve the whole left or right carotid artery with or
without a ﬂow disturbance. The vascular ultrasonographist identiﬁed
plaques in common, internal and external carotids at the time of ultra-
sound measurement. The presence of plaque was coded as yes or no;
however, the degree of stenosis has not been taken into account in the
present study.
2.3. Statistical analysis
Categorical variables are expressed as percentages and continuous
variables are expressed as mean ± SD, with a 95% conﬁdence interval
(CI) and a signiﬁcance level of 5%. Multiple linear regression analysis
was used to assess the effects of each cardiovascular risk factor (hyper-
tension, diabetes mellitus, smoking, dyslipidemia, and CAD) and the
presence of plaque on CIMT. Age and sexwere used as control variables.
The chi-square test with Yates correctionwas used to correlate each riskfactor and the presence of plaque. The logistic regression model was
used to assess all variableswith respect to the presence of plaque. Statis-
tical signiﬁcance was indicated by a value of P b .05. Analyses were per-
formed using IBM SPSS v.20.0 computer software.
3. Results
A total of 553 patients were analyzed. Patients' baseline characteris-
tics are provided in Table 1. At least one risk factor was found in 450
(174 men; 67.6 ± 11.7 years) patients; 103 patients (41 men; 64.6 ±
15.1 years) had no risk factors. Carotid plaque was present in 119
(21.5%) patients: 107 (19.3%) patients with at least one risk factor and
12 (2.1%) patients without risk factors (Table 1). The corrected coefﬁ-
cient of determination was equal to 0.34, indicating that 34% of changes
in CIMT were explained by the variables included in the model. The
CIMT medians were higher in males and in patients with hypertension.
There was a linear increase in mean CIMT of 0.0059 mm for each year
increase in age. An interesting result indicates that 25.33% of the varia-
tions of CIMT are explained by the age of the individual, excluding the
effect of sex, hypertension, diabetes, dyslipidemia, smoking, CAD, and
the presence of plaque. Diabetes, dyslipidemia, CAD, and smoking did
not inﬂuence the CIMT measurements in the present study. The pres-
ence of plaque indicated a tendency to inﬂuence the CIMT measure-
ments (Table 2). However, there was a signiﬁcant difference between
the effects of hypertension on CIMT and the effects of diabetes, dyslipid-
emia, and CAD. The presence of hypertension associated with diabetes
(P = .0061; estimated difference 0.0494 mm) or dyslipidemia (P =
.0016; estimated difference 0.0472 mm) or CAD (P= .0043; estimated
difference 0.0527mm) increases themean CIMTmeasurements. Hyper-
tension did not inﬂuence CIMT when associated with plaque (P =
.2891) or current smoking (P= .1103). The probability of plaque occur-
rence on carotid arteries is inﬂuenced by age and is higher in patients
with dyslipidemia and CAD and had a tendency to be higher in patients
whowere current smokers. Hypertension and diabetes did not cause an
increase in the presence of plaque in the present study (Table 3).
4. Discussion
The main ﬁnding of the present study is that CIMT and carotid
plaque are inﬂuenced differently by traditional cardiovascular risk fac-
tors. Hypertension is the risk factor that most increases the CIMT mea-
surements alone and when associated with diabetes, dyslipidemia,
and CAD,while dyslipidemia and CAD increase the probability of carotid
plaque occurrence. Age inﬂuences both CIMT and plaque, and male sex
increases CIMT values, but not plaque occurrence. Although intima-
media thickness is considered a marker of hypertrophy of intima and
media layers of the artery wall, it is not synonymous with atherosclero-
sis [9–10]. Actually, CIMT and atherosclerosis share commonunderlying
mechanisms for both disease initiation and progression. Pathological in-
timal thickness is characterized as the formation of lipid pools in the
Table 2
Inﬂuence of cardiovascular risk factors on carotid intima-media thickness values according
to multiple linear regression analysis.
Variable Parameters 95% CI P value
Intercept 0.3059 b.001
Sex 0.0280 0.0082–0.0478 .0057
Age 0.0059 0.0050–0.0067 b .001
Hypertension 0.0391 0.0190–0.0592 b .001
Plaque 0.0224 −0.0430–0.0158 .0670
Current smoking 0.0095 0.0201–0.0390 .5293
Diabetes −0.0103 0.0358–0.0151 .4251
Dyslipidemia −0.0081 −0.0273–0.0112 .4109
CAD −0.0136 −0.0430–0.0158 .3636
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Therefore, most investigators do not consider adaptive intimal thicken-
ing as representative of an atherosclerotic disease process. CIMT
assessed by B-mode ultrasound cannot distinguish between intima
plus media layer hypertrophy (which is not considered atherosclerosis)
from plaque initiation. Previous studies [11–13] indicate that CIMT in-
creases with age, and the present study veriﬁed that 25.33% of the var-
iations of CIMT are explained by the age of the individual excluding the
effect of sex, hypertension, diabetes, dyslipidemia, and smoking. Al-
though CIMT has been proposed as a quantitative index of atherosclero-
sis, patients' age should be taken into account. The normal range and
abnormal value and the risk factors associated with CIMT might vary
considerably between different populations and sexes [13–16]. Despite
these facts, CIMTby itself is amarker of generalized atherosclerosis, and,
for example, the relation between intima-media thickness and stroke is
independent of plaque [17]. In support of these ﬁndings, the present
study demonstrates that the presence of plaque is not strongly correlat-
ed with CIMT values. In other words, both pathological features (in-
creased CIMT and plaque) could be present in the same patient but
caused by different risk factors and with independent effects on the ar-
tery wall andwith different clinical prognostic factors. Studies observed
that foam cell lesions, considered types I and II atherosclerosis, are pres-
ent in the third decade of life at the carotid bifurcation and are gradually
replaced by lipid core plaques (types IV and V) in the following decades
[18]. In these initial stages where foam cells are found only in the intima
layer, without ﬁbrous tissue, CIMTmay ormay not progress tomore ad-
vanced lesions, depending on the presence of cardiovascular risk fac-
tors, the medical therapy received by the patient, and genetic
inﬂuences [18–19]. The present study based on a population between
the ﬁfth and seventh decades of life shows the presence of carotid
plaque in just 21.5% of the subjects. Themajority (78.5%) had no carotid
plaque identiﬁed by the B-mode ultrasound, which could justify why
CIMT is not a good predictor of cardiovascular events when compared
to coronary calciﬁcation that has long been known also to occur as a
part of the atherosclerotic process [20–24]. CIMT might just represent
an adaptive response of the arterial wall to age and hypertension, theTable 3
Probability of occurrence of plaque, according to each risk factor.
Variable Without plaque
(N/%)
With plaque
(N/%)
P OR (CI 95%)
Hypertension No 180 (81.08%) 42 (18.92%)
Yes 243 (72.97%) 90 (27.03%) .908 0.97 (0.6–1.57)
Diabetes No 356 (78.24%) 99 (21.76%)
Yes 67 (67.00%) 33 (33.00%) .253 1.38 (0.8–2.38)
Smoking No 372 (75.92%) 118 (24.08%)
Yes 51 (78.46%) 14 (21.54%) .087 1.85 (0.91–3.77)
Dyslipidemia No 240 (78.69%) 65 (21.31%)
Yes 183 (73.2%) 67 (26.8%) .008 1.84 (1.17–2.88)
CAD No 382 (78.93%) 102 (21.07%)
Yes 41 (57.75%) 30 (42.25%) b.001 3.14 (1.76–5.62)
Age b.001 1.11 (1.08–1.13)
Sex .731 1.09 (0.68–1.75)major risk factors in this studypopulation. The absence of carotid plaque
(an established atherosclerotic lesion) does not exclude the probability
of the presence of atherosclerotic plaques in other vascular territories.
But, on the contrary, the presence of carotid plaque had a higher diag-
nostic accuracy for the prediction for future CAD events [25–26]. The
presence of hypertension signiﬁcantly increases CIMT values due to a
hypertrophy of themedia layer of the vesselwall [27], but the formation
of carotid plaque is most strongly related to blood lipid levels as indicat-
ed by the study of Gardener et al. [28]. Hypertension alone or in associ-
ation with other cardiovascular risk factors causes a signiﬁcant increase
in CIMT [4,29–31], and besides the fact that it is considered amajor car-
diovascular risk factor, in the present study, hypertension did not con-
tribute to the occurrence of plaque. This ﬁnding is corroborated in
other studies [32–34] that found no correlation between the presence
of hypertension and the occurrence of atherosclerotic plaques. Howev-
er, the presence of hypertension could accelerate plaque vulnerability
provoking intraplaque hemorrhage and rupture [35]. Although CIMT
and plaque share the effect of atherosclerotic risk factors, they have dif-
ferent natural histories, patterns of risk factors, and prediction of vascu-
lar events [27]. To corroborate these ﬁndings, the present study found
12 (2.1%) patients with carotid plaque but no traditional identiﬁable
cardiovascular risk factor. Another interesting ﬁnding of the present
study is that diabetes mellitus, dyslipidemia, CAD, and smoking did
not inﬂuence the CIMT measurements.
4.1. Study limitations
The present study has some important limitations identiﬁed as
(a) lack of important clinical data; (b) renal control; (c) adopted meth-
od for CIMT measurement and (d) lack of total atherosclerotic burden
assessment. In regard to lack of data, the medical therapy received by
the patients and the time course and treatment of their disease, mainly
diabetes and hypertension, were not provided [36]. However, only 15%
of subjects in the present study presented CAD according to a private
cardiologist's report and no patient had a history of stroke or intermit-
tent claudication suggestive of more advanced macrovascular disease
observed in diabetic patients. Moreover, according to previous studies,
subjects presentedmultiple risk factors,whichmade it difﬁcult to estab-
lishwhether an increase in pathological events could be correlatedwith
the degree of CIMT or with the number and type of risk factors present.
The inﬂuence of the traditional vascular risk factors on the arterial hy-
perplasia was not clearly established as well [37]. Most of subjects in
the present study presented more than one risk factor and received
more than one medical therapy. Assessment of the effect of each medi-
cal therapy on each risk factor as well as of the effect the prescribed
medication on CIMT was not performed. Additionally, the effect of var-
ious antihypertensive drugs on carotid intima-media thickness (CIMT)
produced conﬂicting results [38]. The second limitation addresses the
investigation of the renal function whichwas not performed [39]; how-
ever, there were no patients on maintenance dialysis treatment in the
present study. Third, the method used to measure CIMT was manual,
subject to intra- and inter-observer variability. Finally, the total athero-
sclerotic burden (sum of the total plaque area) and plaque morphology
were also not taken into consideration; only the presence or absence of
carotid plaque was considered.
5. Conclusions
CIMT and carotid plaque have different inﬂuences than traditional
cardiovascular risk factors have. Hypertension is the strongest cardio-
vascular risk factor that increases CIMT, followed by age and male sex,
compared to diabetes mellitus, dyslipidemia, and smoking. The pres-
ence of dyslipidemia and CAD increases the probability of carotid
plaque. The presence of plaque indicated a tendency to correlate with
CIMT. Increased CIMT and plaque could be present in the same patient
51L.A.V. Baroncini et al. / IJC Heart & Vasculature 9 (2015) 48–51caused by different risk factors and having independent effects on the
artery wall and different clinical prognostic outcomes.
6. Perspectives
According to the data from the present study, patientswith dyslipid-
emia and CAD had an increased probability of having carotid plaque.
Hypertension alone or in the presence of diabetes, dyslipidemia or
CAD increases CIMT, but not the probability of carotid plaque. The cur-
rent imagingmethods do not adequately distinguish carotid intimal hy-
perplasia from initial lipid core. There is no current evidence to suggest
that CIMT may progress to atherosclerotic plaque. Further diagnostic
imagingmethods should be capable of distinguishing the adaptive arte-
rial intima-media hypertrophy from initial atherosclerosis lesion, main-
ly in the presence of hypertension alone.
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